Therapy News and Research

RSS

Prostate cancer patients with life expectancies of less than 10 years receive aggressive treatment

National guidelines recommend that men with low- and intermediate -risk prostate cancer and life expectancies of less than 10 years should not be treated with radiation or surgery, since they are unlikely to live long enough to benefit from treatment. Yet it is unknown whether such men are unnecessarily receiving these aggressive local treatments, putting them at risk for potentially debilitating side effects.

2 Dec 2014

U of T professor wins GSK's 2014 Discovery Fast Track Challenge devoted for cancer research

University of Toronto (U of T) Professor Tania Watts is a winner of GSK's 2014 Discovery Fast Track Challenge, which is designed to accelerate the translation of academic research into novel therapies.

2 Dec 2014

Diabetic patients with mild coronary artery disease face increased risk for heart attack

According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease.

2 Dec 2014

Pain medicine specialist receives award for new advances in oral fluid testing

This year's Eastern Pain Society Scientific meeting was held at Mount Sinai Beth Israel Medical Center in New York City in late October and is one of the largest meetings of pain physicians and fellows in the tri-state area.

2 Dec 2014

Sphere Medical to unveil Proxima in-line miniature blood gas analyser at ICS State of the Art meeting

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will be introducing its new Proxima in-line patient dedicated arterial blood gas analyser to the Intensive Care Society (ICS) community at its State of the Art Meeting, ICC London ExCel, 8-10th December.

2 Dec 2014

DEX implant improves visual acuity in patients with diabetic macular oedema

Patients with diabetic macular oedema benefit from intravitreal dexamethasone implants, a study shows, with the treatment improving best-corrected visual acuity with an acceptable safety profile.

1 Dec 2014

Second treated eyes with nAMD functionally more important than first eyes

A real-world study of the characteristics of second treated eyes in patients with neovascular age-related macular degeneration given ranibizumab in the UK National Health Service has shown that these eyes start off with better baseline visual acuity than first treated eyes and, despite a poor response to therapy, maintain this advantage.

1 Dec 2014

MD Anderson professor receives 13th annual City of Florence Prize in Molecular Sciences

Peter Friedl, M.D., Ph.D., professor of genitourinary medical oncology at The University of Texas MD Anderson Cancer Center, has received one of Italy's top scientific awards for his work in imaging and cancer growth, metastasis and therapy response.

1 Dec 2014

Eylea receives Health Canada approval for treatment of CRVO and DME

Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).

1 Dec 2014

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

Clementia Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation to palovarotene, which is being developed for the treatment of fibrodysplasia ossificans progressiva (FOP).

1 Dec 2014

EMA accepts new IMBRUVICA (ibrutinib) application for treatment of Waldenstrom's macroglobulinemia

Pharmacyclics, Inc.today announced the acceptance of a Type II variation application for IMBRUVICA (ibrutinib) by the European Medicines Agency.

1 Dec 2014

CCR5 receptor plays key role in driving prostate cancer metastases

Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone, it is eventually lethal. In a study published online December 1st in the journal Cancer Research, researchers show that the receptor CCR5 best known for its role in HIV therapy, may also be involved in driving the spread of prostate cancer to the bone.

1 Dec 2014

PET/CT may improve differentiation of PTSD from MTBI

Hybrid imaging with positron emission tomography and computed tomography (PET/CT) in the pituitary region of the brain is a promising tool for differentiating military veterans with post-traumatic stress disorder (PTSD) from those with mild traumatic brain injury (MTBI), according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2014

New vaccine shows promise in patients with metastatic breast cancer

A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients' immune systems to attack tumor cells and helped slow the cancer's progression.

1 Dec 2014

Phenotyping human diseases in mice: an interview with Professor Carola Vinuesa

One of the main obstacles to finding effective therapies for human diseases has been our limited understanding of disease pathogenesis: we lack detailed knowledge of the cellular and molecular mechanisms that lead to the development of disease.

30 Nov 2014

iCo Therapeutics announces corporate update and Q3 2014 financial results

iCo Therapeutics ("iCo" or "the Company"), today reported financial results for the nine months ended September 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").

29 Nov 2014

Philips launches Ambient Experience patient in-bore solution to reduce patient anxiety during MRI scans

Royal Philips announced the launch of the Ambient Experience patient in-bore solution designed to reduce patient anxiety and movement during magnetic resonance imaging (MRI) examinations.

29 Nov 2014

New active substance effectively combats Philadelphia chromosome-positive leukaemia

Haematologists from Goethe University Frankfurt, working with a Russian pharmaceutical company, have developed a new active substance that effectively combats the most aggressive forms of Philadelphia chromosome-positive leukaemia.

29 Nov 2014

Salford researchers to support adoption of CAD technologies in footwear manufacturing

A University of Salford team headed by Dr Anita Williams, Senior Lecturer at the School of Health Sciences, is moving into its second year of delivering sector-leading education content for industries in the UK and European Union, as part of an EU Leonardo da-Vinci funded project - INGA3D.

28 Nov 2014

New research examines effect on Tourette's sufferers when exposed to their own image

Tourette's syndrome is characterised by tics caused in many by premonitory urges; sensations which give patients compulsion to act to relieve discomfort. Habit reversal therapy conditions patients into heightened awareness of premonitory urges and forced counteraction of the tic.

28 Nov 2014

Therapy News and Research

Prostate cancer patients with life expectancies of less than 10 years receive aggressive treatment

U of T professor wins GSK's 2014 Discovery Fast Track Challenge devoted for cancer research

Diabetic patients with mild coronary artery disease face increased risk for heart attack

Pain medicine specialist receives award for new advances in oral fluid testing

Sphere Medical to unveil Proxima in-line miniature blood gas analyser at ICS State of the Art meeting

DEX implant improves visual acuity in patients with diabetic macular oedema

Second treated eyes with nAMD functionally more important than first eyes

MD Anderson professor receives 13th annual City of Florence Prize in Molecular Sciences

Eylea receives Health Canada approval for treatment of CRVO and DME

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

EMA accepts new IMBRUVICA (ibrutinib) application for treatment of Waldenstrom's macroglobulinemia

CCR5 receptor plays key role in driving prostate cancer metastases

PET/CT may improve differentiation of PTSD from MTBI

New vaccine shows promise in patients with metastatic breast cancer

Phenotyping human diseases in mice: an interview with Professor Carola Vinuesa

iCo Therapeutics announces corporate update and Q3 2014 financial results

Philips launches Ambient Experience patient in-bore solution to reduce patient anxiety during MRI scans

New active substance effectively combats Philadelphia chromosome-positive leukaemia

Salford researchers to support adoption of CAD technologies in footwear manufacturing

New research examines effect on Tourette's sufferers when exposed to their own image

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News